We serve Chemical Name:4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole CAS:957062-77-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole
CAS.NO:957062-77-0
Synonyms:4-bromo-1-(2-bromophenyl)sulfonylpyrazole
Molecular Formula:C9H6Br2N2O2S
Molecular Weight:366.02900
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:485ºC at 760mmHg
Density:2.01g/cm3
Index of Refraction:1.708
PSA:60.34000
Exact Mass:363.85200
LogP:3.72590
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-bromo-1-(2-bromophenyl)sulfonylpyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-1-(2-bromophenyl)sulfonylpyrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-bromo-1-(2-bromophenyl)sulfonylpyrazole Use and application,4-bromo-1-(2-bromophenyl)sulfonylpyrazole technical grade,usp/ep/jp grade.
Related News: The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. 4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole manufacturer Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. 4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole supplier The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. 4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 4-Bromo-1-((2-bromophenyl)sulfonyl)-1H-pyrazole factory This includes chemical APIs.
